X

Quality Statement

Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety.

X

Image Use Agreement

By downloading, copying, or making any use of the images located on this website (“Site”) you acknowledge that you have read and understand, and agree to, the terms of this Image Usage Agreement, as well as the terms provided on the Legal Notices webpage, which together govern your use of the images as provided below. If you do not agree to such terms, do not download, copy or use the images in any way, unless you have written permission signed by an authorized Pacific Biosciences representative.

Subject to the terms of this Agreement and the terms provided on the Legal Notices webpage (to the extent they do not conflict with the terms of this Agreement), you may use the images on the Site solely for (a) editorial use by press and/or industry analysts, (b) in connection with a normal, peer-reviewed, scientific publication, book or presentation, or the like. You may not alter or modify any image, in whole or in part, for any reason. You may not use any image in a manner that misrepresents the associated Pacific Biosciences product, service or technology or any associated characteristics, data, or properties thereof. You also may not use any image in a manner that denotes some representation or warranty (express, implied or statutory) from Pacific Biosciences of the product, service or technology. The rights granted by this Agreement are personal to you and are not transferable by you to another party.

You, and not Pacific Biosciences, are responsible for your use of the images. You acknowledge and agree that any misuse of the images or breach of this Agreement will cause Pacific Biosciences irreparable harm. Pacific Biosciences is either an owner or licensee of the image, and not an agent for the owner. You agree to give Pacific Biosciences a credit line as follows: "Courtesy of Pacific Biosciences of California, Inc., Menlo Park, CA, USA" and also include any other credits or acknowledgments noted by Pacific Biosciences. You must include any copyright notice originally included with the images on all copies.

IMAGES ARE PROVIDED BY Pacific Biosciences ON AN "AS-IS" BASIS. Pacific Biosciences DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, INCLUDING, BUT NOT LIMITED TO, NON-INFRINGEMENT, OWNERSHIP, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. IN NO EVENT SHALL Pacific Biosciences BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES OF ANY KIND WHATSOEVER WITH RESPECT TO THE IMAGES.

You agree that Pacific Biosciences may terminate your access to and use of the images located on the PacificBiosciences.com website at any time and without prior notice, if it considers you to have violated any of the terms of this Image Use Agreement. You agree to indemnify, defend and hold harmless Pacific Biosciences, its officers, directors, employees, agents, licensors, suppliers and any third party information providers to the Site from and against all losses, expenses, damages and costs, including reasonable attorneys' fees, resulting from any violation by you of the terms of this Image Use Agreement or Pacific Biosciences' termination of your access to or use of the Site. Termination will not affect Pacific Biosciences' rights or your obligations which accrued before the termination.

I have read and understand, and agree to, the Image Usage Agreement.

I disagree and would like to return to the Pacific Biosciences home page.

Pacific Biosciences
Contact:
 Pricing
Questions
Photo Release — Pacific Biosciences Launches the PacBio(R) RS II Sequencing System Background

Press Release

Photo Release — Pacific Biosciences Launches the PacBio(R) RS II Sequencing System

Thursday, April 11, 2013

MENLO PARK, Calif., April 11, 2013 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced the launch of the PacBio® RS II — a new Single Molecule, Real-Time (SMRT®) DNA Sequencing System that provides the industry’s highest consensus accuracy and longest read lengths, with double the throughput from the previous version of the system.

The PacBio RS II System offers a simple, fast, end-to-end workflow for SMRT Sequencing in research areas including infectious disease and microbiology, agriculture, and complex genetic diseases with repeat expansions.

A photo accompanying this release is available at https://www.globenewswire.com/newsroom/prs/?pkgid=18068

The PacBio RS II allows scientists to rapidly and cost effectively generate finished genome assemblies, reveal and understand epigenomes, and characterize genomic variation. Based on the company’s revolutionary SMRT Sequencing technology, the RS II can generate average read lengths of 5,000 base pairs, with the longest reads above 20,000 base pairs in length. The PacBio RS II System, including consumables and software, provides a simple, fast, end-to-end workflow for SMRT Sequencing in research areas including infectious disease and microbiology, agriculture, and complex genetic diseases with repeat expansions.

With the PacBio RS II, the number of simultaneously observable sequencing reactions is doubled, which effectively doubles the throughput of the system. This increase in the number of reads will drive new applications such as full-length cDNA analysis and full-length 16S metagenomics. The PacBio RS II features PacBio’s C2 and XL chemistries, new analysis software with automated de novo assembly, and other improvements released in the past two years, including: increased consensus accuracy to greater than 99.999% (Q50), a quadrupling of average
read lengths, and a 10-fold reduction in input DNA required.

“In addition to providing more, high-quality data in a highly robust system, the PacBio RS II includes all of the performance improvements we have made since we launched the commercial PacBio RS System in 2011,” said Kevin Corcoran, Senior Vice President of Market Development. “The combined improvements in accuracy, reliability, and throughput, as well as increased cost efficiencies, are what many researchers have been waiting for in order to adopt SMRT Sequencing in their laboratories.”

Richard Gibbs, Ph.D., Professor and Chair of the Department of Molecular and Human Genetics at Baylor College of Medicine and Director of the Human Genome Sequencing Center, was among the early access users of the PacBio RS. “I have been very impressed with the progress Pacific Biosciences has made with this unique technology. With each performance upgrade, our ability to handle more complex projects increases. We are now using the system to improve the sequence of mammalian genomes.”

Customers with existing PacBio RS Systems can purchase an upgrade, which will convert the PacBio RS to the new PacBio RS II. Installations of the new PacBio RS II System are expected to begin in the second quarter of 2013. For more information please visit www.pacb.com/rsII.

About Pacific Biosciences

Pacific Biosciences of California, Inc. (Nasdaq:PACB) offers the PacBio® RS II Sequencing System to help scientists solve genetically complex problems. Based on its novel Single Molecule, Real-Time (SMRT®) Sequencing technology, the company’s products enable: targeted sequencing to more comprehensively characterize genetic variations; de novo genome assembly to more fully identify, annotate and decipher genomic structures; and DNA base modification identification to help characterize epigenetic regulation and DNA damage. By providing access to information that was previously inaccessible, Pacific Biosciences enables scientists to increase their understanding of biological systems.

The photo is also available via AP PhotoExpress.

CONTACT: Media:

         Maurissa Messier

         For Pacific Biosciences

         760.539.7417

         maurissa@bioscribe.com



         Investors:

         Trevin Rard

         Pacific Biosciences

         650.521.8450

         ir@pacificbiosciences.com

Source: Pacific Biosciences of California, Inc.

News Provided by Acquire Media

All Press Releases

Press Release

Pacific Biosciences Announces Planned Retirement of CEO, Dr. Michael Hunkapiller

Wednesday, June 10, 2020

Stay
Current

Visit our blog »